Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

12-1-2021

Differential and synergistic effects of low birth weight and
western diet on skeletal muscle vasculature, mitochondrial lipid
metabolism and insulin signaling in male guinea pigs
Kristyn Dunlop
Western University

Ousseynou Sarr
Western University

Nicole Stachura
Western University

Lin Zhao
Western University

Karen Nygard
Western University

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Dunlop, Kristyn; Sarr, Ousseynou; Stachura, Nicole; Zhao, Lin; Nygard, Karen; Thompson, Jennifer A.;
Hadway, Jennifer; Richardson, Bryan S.; Bureau, Yves; Borradaile, Nica; Lee, Ting Yim; and Regnault,
Timothy R.H., "Differential and synergistic effects of low birth weight and western diet on skeletal muscle
vasculature, mitochondrial lipid metabolism and insulin signaling in male guinea pigs" (2021). Paediatrics
Publications. 1802.
https://ir.lib.uwo.ca/paedpub/1802

Authors
Kristyn Dunlop, Ousseynou Sarr, Nicole Stachura, Lin Zhao, Karen Nygard, Jennifer A. Thompson, Jennifer
Hadway, Bryan S. Richardson, Yves Bureau, Nica Borradaile, Ting Yim Lee, and Timothy R.H. Regnault

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1802

nutrients
Article

Differential and Synergistic Effects of Low Birth Weight and
Western Diet on Skeletal Muscle Vasculature, Mitochondrial
Lipid Metabolism and Insulin Signaling in Male Guinea Pigs
Kristyn Dunlop 1,† , Ousseynou Sarr 1,† , Nicole Stachura 1 , Lin Zhao 1 , Karen Nygard 2 , Jennifer A. Thompson 3,4 ,
Jennifer Hadway 5 , Bryan S. Richardson 1,5,6,7 , Yves Bureau 8 , Nica Borradaile 1 , Ting-Yim Lee 5,9
and Timothy R. H. Regnault 1,5,6,7, *
1

2
3

4
5

6
7



Citation: Dunlop, K.; Sarr, O.;
Stachura, N.; Zhao, L.; Nygard, K.;

8
9

*
†

Department of Physiology and Pharmacology, Western University, London, ON N6A 3K7, Canada;
dunlopk13@gmail.com (K.D.); osarr@uwo.ca (O.S.); nstachura2024@meds.uwo.ca (N.S.);
lzhao3@uwo.ca (L.Z.); brichar1@uwo.ca (B.S.R.); nica.borradaile@schulich.uwo.ca (N.B.)
Biotron Laboratory, Western University, London, ON N6A 3K7, Canada; knygard@uwo.ca
Department of Physiology and Pharmacology, Libin Cardiovascular Institute of Alberta,
Calgary, AB T2N 4N1, Canada; jennifer.thompson2@ucalgary.ca
Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada
Lawson Health Research Institute, London, ON N6C 2R5, Canada; jhadway@uwo.ca (J.H.);
tlee@uwo.ca (T.-Y.L.)
Children’s Health Research Institute, London, ON N6C 2V5, Canada
Department of Obstetrics and Gynaecology, Western University, London, ON N6A 3K7, Canada
Departments of Medical Biophysics, Western University, London, ON N6A 3K7, Canada; ybureau@uwo.ca
Departments of Medical Imaging, Medical Biophysics, and Oncology, Robarts Research Institute,
Western University, London, ON N6A 3K7, Canada
Correspondence: tim.regnault@uwo.ca; Tel.: +1-519-661-2111 (ext. 83528); Fax: +1-519-661-3827
These authors contributed equally to this work.

Thompson, J.A.; Hadway, J.;
Richardson, B.S.; Bureau, Y.;
Borradaile, N.; et al. Differential and
Synergistic Effects of Low Birth
Weight and Western Diet on Skeletal
Muscle Vasculature, Mitochondrial
Lipid Metabolism and Insulin
Signaling in Male Guinea Pigs.
Nutrients 2021, 13, 4315. https://
doi.org/10.3390/nu13124315
Received: 13 October 2021
Accepted: 25 November 2021
Published: 29 November 2021

Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affiliations.

Abstract: Low birth weight (LBW) offspring are at increased risk for developing insulin resistance,
a key precursor in metabolic syndrome and type 2 diabetes mellitus. Altered skeletal muscle
vasculature, extracellular matrix, amino acid and mitochondrial lipid metabolism, and insulin
signaling are implicated in this pathogenesis. Using uteroplacental insufficiency (UPI) to induce
intrauterine growth restriction (IUGR) and LBW in the guinea pig, we investigated the relationship
between UPI-induced IUGR/LBW and later life skeletal muscle arteriole density, fibrosis, amino
acid and mitochondrial lipid metabolism, markers of insulin signaling and glucose uptake, and
how a postnatal high-fat, high-sugar “Western” diet (WD) modulates these changes. Muscle of
145-day-old male LBW glucose-tolerant offspring displayed diminished vessel density and altered
acylcarnitine levels. Disrupted muscle insulin signaling despite maintained whole-body glucose
homeostasis also occurred in both LBW and WD-fed male “lean” offspring. Additionally, postnatal
WD unmasked LBW-induced impairment of mitochondrial lipid metabolism, as reflected by increased
acylcarnitine accumulation. This study provides evidence that early markers of skeletal muscle
metabolic dysfunction appear to be influenced by the in utero environment and interact with a
high-fat/high-sugar postnatal environment to exacerbate altered mitochondrial lipid metabolism,
promoting mitochondrial overload.
Keywords: placental insufficiency; intrauterine growth restriction; low birth weight; skeletal muscle;
insulin resistance; mitochondria; lipid metabolism; Western diet; fetal programming; muscle vessels
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1. Introduction
Metabolic syndrome (MetS) is an important risk factor for cardiovascular disease
and type 2 diabetes mellitus (T2DM), with increased morbidity and mortality [1]. Insulin
resistance is the primary determinant of the components of the MetS, including obesity,
glucose intolerance, dyslipidemia, and hypertension, and is evident before overt disease
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develops [1,2]. Insulin resistance develops in key insulin target tissues, including muscle,
and is the result of altered fatty acid transport and oxidation, intramyocellular lipid
accumulation, and reduced mitochondrial oxygen uptake in skeletal muscle [3–5]. Insulin
resistance is also characterized by altered insulin signaling responses associated with
impaired vasculature, increased acylcarnitine contents, altered amino acid availability, and
diminished glucose uptake in skeletal muscle [6–12].
The increasing prevalence of T2DM/insulin resistance has been widely reported to
occur in conjunction with the increasing consumption of an energy-dense, high-fat/highsugar diet or a Western diet (WD) [13,14]. Prior to whole-body insulin resistance being
detected, multiple organs develop insulin resistance, with muscle developing insulin resistance prior to other organs, such as the liver and white adipose tissue, with a cascade effect
then occurring that is finally displayed as whole-body insulin resistance and glucose intolerance [15,16]. Early phases of insulin resistance development in skeletal muscle include
extracellular matrix remodeling with increased physical barriers for insulin and glucose
transport and decreased vascular insulin delivery [17]. Moreover, chronic consumption of
a high-fat diet generates fatty acid oxidation rates in muscle that outpace the tricarboxylic
acid cycle (TCA), leading to incomplete β-oxidation with intramitochondrial accumulation of acyl-CoAs and respective acylcarnitines [6,18]. This mitochondrial overload with
acylcarnitines accumulation may then promote alterations in the phosphorylation status
of insulin signaling intermediates as key mediators of the pathogenesis of skeletal muscle
insulin resistance [6,19]. In conjunction with altered β-oxidation pathways, skeletal muscle
amino acid availability is also impacted, all contributing to the development of skeletal
muscle insulin resistance [8,18].
Animal and human studies have now clearly shown that conditions associated with
the development of MetS can also be attributed to an adverse in utero environment, such
as observed that with uteroplacental insufficiency (UPI)-induced intrauterine growth
restriction (IUGR) [19–23]. IUGR resulting in low birth weight (LBW) is now recognized
as a central programming factor in lifelong impairments in muscle development and
metabolism [24]. Indeed, fewer capillaries per muscle fiber are found in LBW piglets [25],
and in fetal IUGR sheep, skeletal muscle amino acid concentrations are altered, indicating
impairments in amino acid metabolism [26]. Additionally, gastrocnemius muscle of lean
adult glucose-intolerant and insulin-resistant male LBW rat offspring displays inefficient
insulin-induced insulin receptor (IR), insulin receptor substrate-1 (IRS-1), and Akt substrate
of 160 kDa (AS160) phosphorylation, as well as impaired glucose transporter type 4
translocation in gastrocnemius muscle [27]. Metabolomic studies in blood of IUGR/LBW
human neonates have shown abnormalities in amino acids and increases in acylcarnitine
content [28,29], while studies of the blood of adult mice born with LBW have shown
altered β-oxidation with increased blood acetylcarnitine (C2) and short-chain acylcarnitines
(C3–C5) [30], indicating mitochondrial overload due to incomplete fatty oxidation in
later life, changes which have been associated with later life adult metabolic disease
risk [31,32]. Furthermore, skeletal muscle in postnatal UPI-induced IUGR/LBW rats
shows downregulation of insulin receptor beta (IRβ) and reduced phosphorylation of
phosphoinositide 3-kinase (PI3K)/Protein kinase (AKT) at serine 473 (phospho-AktSer473 ),
while that in young-adult men born LBW shows reduced insulin-signaling proteins [20],
indicating disruption in insulin signaling [33,34]. Together, these studies highlight that
skeletal muscle structure, metabolism, and insulin signaling pathways are susceptible to
the in utero environment and may underly persistent changes in the offspring associated
with early adulthood development of pre-clinical markers of MetS.
Recently, evidence has suggested that in utero influences and secondary insults in
postnatal life, such as excessive energy supply (e.g., WD), may have a synergistic effect,
further exacerbating an already dysfunctional system and promoting an earlier, more
extreme onset of MetS [35]. In addition, there has recently been increased recognition of
insulin resistance and T2DM among the pediatric population, attributed to a combination
of genetic predisposition and environmental factors, namely sedentary lifestyle and energy-
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dense foods [36]. Therefore, the contribution of the in utero environment to alterations in
muscle structure and metabolic function should not be ignored when assessing children
born with LBW and the risk of developing metabolic dysfunctions, such as insulin resistance
and T2DM, at an earlier age. The Western diet is widely available in society, and given
that UPI is the most common in utero insult leading to IUGR/LBW [37,38] and high
prevalence of IUGR/LBW infants [39] with increased metabolic disease risk later in life
may be greater than currently thought [40], there is great importance in understanding
the specific developmental pathways to MetS. Here, we sought to identify alterations in
the skeletal muscle extracellular matrix, vasculature, amino acid and mitochondrial lipid
metabolism, glucose uptake, and insulin signaling following UPI-induced IUGR/LBW
independently, and in conjunction with early postnatal exposure to a Western diet, in
young adulthood.
2. Materials and Methods
2.1. Ethics Statement
All investigators understood and followed the ethical principles as outlined by
Grundy [41] and the study design was informed by the ARRIVE guidelines [42].
2.2. Animal Handling
Time-mated pregnant Dunkin–Hartley guinea pigs (Charles River Laboratories, Wilmington, MA, USA) were housed in a constant temperature- (20 ◦ C) and humidity-controlled
(30%) environment with a 12 h light/dark cycle. All animals had ad libitum access to
standard guinea pig chow (LabDiet diet 5025) and tap water. All pregnant guinea pigs underwent partial ablation of branches of uterine artery to induce uteroplacental insufficiency
and intrauterine growth restriction (IUGR) [43]. At mid-gestation (~32 days, term ~67 days),
sows were anesthetized in an anesthetic chamber (4–5% isoflurane with 2 L/min O2 , followed by 2.5–3% isoflurane with 1 L/min O2 for maintenance). Immediately following
induction of anesthesia, a subcutaneous injection of Rubinol (Glycopyrrolate, 0.01 mg/kg,
Sandoz Can Inc., Montreal, QC, Canada) was administered. A midline incision was made
below the umbilicus, exposing the bicornate uterus. Arterial vessels feeding one horn of
the uterus were identified and every second branch was cauterized using an Aaron 2250
electrosurgical generator (Bovie Medical, Clearwater, FL, USA). Immediately after surgery,
a subcutaneous injection of Temgesic (Buprenorphine, 0.025 mg/kg, Schering-Plough Co.,
Kenilworth, NJ, USA) was administered, and recorded monitoring continued following
surgery for 3 days.
Sows delivered spontaneously at term, at which time pup weight, length, abdominal
circumference, and biparietal distance were measured. Following the pupping period, all
birth weights were collated and if birth weight was below the 25th percentile, these guinea
pigs were allocated to the low birth weight (LBW) group, and if birth weight was between
the 25th and 75th percentile, these pups were allocated to the normal birth weight (NBW)
group (Figure 1).
Based on these criteria, FGR pups were below 80 g and NBW pups were above 90 g,
in accordance with previously reported pup weight ranges in uterine artery ligation and
maternal feed restriction guinea pig models [44]. Animals between 80 g and 90 g (grey
hatched bar) were excluded from analyses (Figure 1).
Pups remained with their dams during the 15-day lactation period. Five days prior
to weaning, all pups were introduced to a synthetic control diet (CD, Harlan Laboratories
TD.110240) [45] and weaned on postnatal day (PND) 15 into individual cages. At this
time, guinea pig offspring were randomized to either a CD or a Western (WD, Harlan
Laboratories TD.110239) diet (Supplementary Table S1) [45]. Carbohydrates comprised
60% of total kilocalories in the CD [distribution (% by weight): 10% sucrose, 40% corn
starch] and 33% of total kilocalories in the WD (distribution (% by weight): 19% sucrose,
6.5% fructose, 9% corn starch). The diets differed in kilocalorie density (3.4 vs. 4.2 kcal g−1 )
but were matched for protein and macronutrients on the basis of kilocalorie density. To-
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tal fat constituted 18% of kilocalories in the CD (2.8% saturated fatty acids (SFA), 4.4%
monounsaturated fatty acids (MUFA), 11.2% polyunsaturated fatty acids (PUFA)) from
soybean oil and 45% of kilocalories in the WD (31.7% SFA, 11.8% MUFA, 1.8% PUFA)
from a combination of coconut oil, lard, and cocoa butter). The WD contained also 0.25%
cholesterol. Consequently, the WD mimics the human WD [46,47], being high in saturated
fats, refined sugars (sucrose and fructose), and cholesterol, and low in polyunsaturated
fats. To avoid litter effects, only one LBW and one NBW animal from a single litter was
Nutrients 2021, 13, x FOR PEER REVIEWassigned to each diet. Only male pups were examined for this study. From the4 time
of 31 of
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an anesthetic chamber (4–5% isoflurane with 2 L/min O2 ) and then transferred to a tightfitting nose cone (2.5–3% isoflurane with 1 L/min O2 for maintenance). While anesthetized,
each guinea pig was injected with ~18.5 MBq of 18 F-fluoro-deoxy-glucose (FDG) via the
pedal vein. Following injection, guinea pigs were recovered and returned to their cages.
After approximately 40 min, allowing for the uptake of the radiolabeled FDG, guinea
pigs were anesthetized (4–5% isoflurane with 2 L/min O2 ) and placed on a micro-PET
scanner (GE eXplore Vista, GE Healthcare, Chicago, IL, USA) fitted with a nose cone to
inhale 2.5–3% isoflurane with 1 L/min O2 for maintenance of anesthesia. Emission scans
for the leg regions were acquired for 20 min, then reconstructed in 3D mode. Resulting
images were analyzed with a custom MATLAB-designed program (MATLAB; MathWorks
Inc., Natick, MA, USA), where regions of interest were drawn around the muscles of the
hindlimb. Measurements of standard uptake value (SUV) were obtained by applying FDG
dosage and body weight of the pup to the following equation [51,52]:
SUV =

Activity in Tissue
( Administered Activity/Body Weight)

Whole-body adipose tissue, muscle, and bone were quantified with computed tomography (CT) at PND110, as previously described [53].
2.6. Tissue Collection
At PND145, guinea pigs were sacrificed by CO2 inhalation [49] following an overnight
fast. Gastrocnemius muscle, a representative muscle with mixed composition of oxidative
and glycolytic fibers [54], was removed and trimmed of excess fat and connective tissue,
then flash frozen in liquid nitrogen for subsequent analysis. The subset of muscle samples
used for histological analysis were fixed in 4% paraformaldehyde and further embedded
in paraffin wax (both left and right muscles in a single block).
2.7. Determination of Fatty Infiltration, Arteriole Density, and Interstitial Fibrosis in
Skeletal Muscle
All tissue processing and cutting, as well as hematoxylin and eosin (H&E) staining,
were performed at the Molecular Pathology Core Facility (Robarts Research Institute,
London, ON, Canada). Cross-sections (5 µm) were cut towards the middle of the muscle
sample. For analysis of muscle fat deposition, sections were stained with H&E. Interstitial
adipocytes were not observed within the muscle sections; therefore, fat deposition was
not quantified.
To determine arteriole densities, sections were immunostained with alpha-smooth
muscle actin (α-SMA) antibody (Clone 1A4, DAKO, M0851, Agilent Technologies, Santa
Clara, CA, USA). Slides containing gastrocnemius muscle sections were deparaffinized in
xylene and rehydrated using a graded ethanol series. Heat-induced epitope retrieval (HIER)
was then performed within an antigen retriever (EMS, Hatfield, PA, USA) using 10 mM
Tris HCl/1 mM EDTA pH 9.0. Slides were washed three times in phosphate-buffered
saline (PBS). A hydrophobic pen (Dako, Agilent Technologies, Santa Clara, CA, USA) was
then used to circle the tissue samples and subsequent incubations were done within a
humidified chamber. To reduce non-specific binding, tissues were treated with Background
Sniper (Biocare Medical, Concord, CA, USA) for ten minutes. After a brief wash with PBS,
primary antibody α-SMA (1:2000 dilution) was applied to the tissue and microscope slides
were incubated overnight at 4 ◦ C. The following day, slides were rinsed three times with
PBS, and the secondary antibody, anti-mouse Alexa 660 (ThermoFisher Scientific, London,
ON, Canada) (pseudo-green, 1:400 dilution), was applied. The slides were allowed to
incubate for 45 min at room temperature, followed by a PBS wash (2 × 5 min). Tissue
was then counterstained with 40 , 6-diamidino-2-phenylindole, dihydrochloride (DAPI)
(ThermoFisher Scientific, London, ON, Canada) (1:300 dilution) for two minutes, followed
by a brief PBS wash. Coverslips were mounted onto the slides (Fisher Scientific, Ottawa,
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ON, Canada) using 60 µL of Prolong Diamond Mounting Media (ThermoFisher Scientific,
London, ON, Canada) and dried overnight prior to imaging.
Imaging and arteriole quantification were performed in a blinded manner. A total
of six images spaced across the entirety of the specimen were taken per section using
AxioImager Z1 fluorescent microscope (Carl Zeiss Ltd., North York, ON, Canada). Only
cross-sectional areas of the muscle were included for quantification. Multichannel images of
each field of view included a matching channel image of the natural tissue autofluorescence
for use in measuring total myofiber area. Vessels positive for α-SMA were manually
counted, with the exception of larger arteries. Total myofiber areas (mm2 ) were quantified
using a customized, automated ImagePro software macro (Media Cybernetics, Rockville,
MD, USA). All analyses were performed on raw camera files. Binary thresholds for
automatically counting myofiber area were generated using the OTSU minimum variance
algorithm on the raw greyscale versions of the auto-fluorescent signal channel. Vessel
numbers were then normalized to myofiber areas and the resulting densities were averaged
across the six images for each guinea pig.
To determine collagen deposition (fibrosis), Masson’s trichrome stain was used. Slides
containing muscle sections were deparaffinized in xylene and rehydrated using a graded
ethanol series. Tissue was then placed in Harris hematoxylin solution for 30 s, briefly
sprayed with water, then dipped three times in HCl (1%) made in ethanol (70%). Slides were
then placed in Biebrich scarlet (Ponceau BS)/acid fuchsin (1% acid fuchsin/1% acetic acid)
mixture for 2 min, followed by a quick rinse in distilled water. Muscle sections were then
placed in a solution containing equal parts of phosphotungstic (5%) and phosphomolybdic
(5%) acids for 1 min, followed by 3 min in Fast Green FCF (1%) made in acetic acid (1%).
Subsequently, the slides were placed in acetic acid (1%) until collagen retained only a green
colour. At this time, tissue was quickly rinsed in 95% alcohol, then dehydrated using a
graded series of ethanol, followed by xylene. Coverslips were mounted onto the slides
(Fisher Scientific, Ottawa, ON, Canada) using Permount (Fisher Scientific, Ottawa, ON,
Canada) and dried overnight before imaging.
Following staining, virtual slides of each specimen were created using an Aperio
AT2 Scanner system (Leica Biosystems, Inc., Buffalo Grove, IL, USA, Aperio). Aperio
ImageScope v.6.25 software was then used to view the digital slides and extract five images
(1890 µm2 each) covering the span of the muscle in a blinded manner. Muscle fibrosis areas
for each image were determined using a customized, automated ImagePro software macro.
Binary counting thresholds for the macro were created through RGB colour samples across
a variety of images and tested for accuracy against negative areas of the tissue. Functional
collagen surrounding the muscle was excluded from quantification. The collagen areas
were normalized to total myofiber area, then averaged across the five images per animal
and reported as percentages.
2.8. RNA Extraction and Quantitative Real-Time PCR (qRT-PCR)
Total RNA was extracted from gastrocnemius muscle by homogenizing ~20 mg in
1 mL Trizol (Invitrogen, Carlsbad, CA, USA) and following the manufacturer’s protocol. Total RNA was subsequently treated with deoxyribonuclease for 30 min to eliminate genomic
DNA. Quantification of RNA was performed with the ND-1000 NanoDrop spectrophotometer (Thermo Fisher Scientific, Rochester, NY, USA). Each sample was also assessed for
RNA integrity using 1.2% agarose electrophoresis with RedSafe™ (iNtRON Biotechnology,
Sangdaewon-Dong, Joongwon-Ku, Sungnam, Kyungki-Do, 462-120, KOREA). Complementary DNA was synthesized from 2 µg of purified RNA, reverse-transcribed using M-MLV
Reverse Transcriptase (Life Technologies, Burlington, ON, Canada) and a C1000 Thermal
Cycler (Bio-Rad, Mississauga, ON, Canada). All primers were designed from guinea
pig (cavia porcellus) sequences using NCBI/Primer-BLAST tool (Supplementary Table S2).
Standard curves for each primer pair (three pairs for each gene) were generated from serial
dilutions of cDNA for determination of primer efficiencies. PCR efficiencies for each primer
set were 90–105% (Supplementary Table S2). Melting curve analysis and presence of a
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single amplicon at the expected size in a 1.8% agarose gel were used to confirm amplification of a single product. cDNA products were used as templates for qRT-PCR assessment
of gene expression using the SYBR green system (SensiFast™ Sybr No-Rox Mix; Bioline,
London, UK) on a Bio-Rad CFX384 real-time system instrument (Bio-Rad, Mississauga,
ON). Each sample was run in triplicate. Forty cycles of amplification were performed, with
each cycle consisting of: denaturation at 95 ◦ C for 15 s, annealing at the pre-determined
temperature for each primer set for 20 s, and extension at 72 ◦ C for 20 s. Control samples
containing no cDNA were used to confirm the absence of DNA contamination. The transcript level of target genes was normalized to β-actin; there were no differences in the
expression of β-actin between experimental groups. The fold expression of each individual
target gene was determined by the 2−∆∆Ct method [55].
2.9. Protein Extraction and Immunoblotting
Gastrocnemius samples (~50 mg each) were homogenized in 0.5 mL ice-cold lysis
buffer (pH 7.4, 50 mM Tris-HCl, 1% NP-40, 0.5% Sodium-deoxycholate, 150 mM NaCl, 0.1%
sodium dodecyl sulfate) containing protease inhibitor cocktail (Cocktail set 1, Calbiochem,
Bilerica, MA, USA) and phosphatase inhibitors (25 mM NaF, 1 mM Na2VO4). Homogenates
were incubated on ice for 15 min, then subjected to sonication with 3–5 bursts at 30% output
(MISONIX: ultrasonic liquid processor), followed by centrifugation at 15,000 g for 30 min
at 4 ◦ C. The supernatant was collected and Pierce BCA Protein Assay (Thermo Scientific,
Waltham, MA, USA) was employed for protein quantification.
Protein samples were separated using 7.5%, 10%, or 12% Bis-Tris gels, and transferred
onto Immobilon transfer membranes (EMD Millipore, Billerica, MA, USA) via wet transfer.
Consistent protein loading and sufficient transfer of proteins was confirmed using 1×
amido black stain and images were captured using a Versadoc System (Bio-Rad, Mississauga, ON, Canada). Membranes were blocked overnight at 4 ◦ C with Tris-buffered saline
(TBS)/0.1% Tween 20 (Thermo Fisher Scientific, Waltham, MA, USA) containing 5% skim
milk or 5% bovine serum albumin (BSA; AMRESCO, Solon, OH, USA), as indicated in
Supplementary Table S3. Following blocking, membranes were incubated with primary
antibodies in Tris-buffered saline (TBS)/0.1% Tween 20 containing 5% skim milk or BSA,
at 4 ◦ C and following dilutions specified in Supplementary Table S3. The blots were then
washed in TBS/0.1% Tween 20 and incubated at 1 h room temperature with the appropriate secondary conjugated antibody (Supplementary Table S3). The chemiluminescence
signal was captured with the ChemiDoc MP Imaging System (Bio-Rad) and protein band
densitometry was determined using the Image Lab software (Bio-Rad). Ponceau staining
was used as the loading control, as previously published [56,57]
2.10. Thin Liquid Chromatography and Gas Chromatography
Total lipids were extracted from gastrocnemius muscle (~160 mg) using a protocol
adapted from Klaiman et al. [58]. Briefly, tissue samples were homogenized in 850 µL 1:1
chloroform:methanol (v/v) containing 0.1% butylated hydroxytoluene (BHT) [59]. Following homogenization, 8.5 mL of 2:1 chloroform:methanol (v/v) + 0.1% BHT was added to
each sample. Next, 1.7 mL of 0.25% KCl was added to separate the aqueous solutes, then
incubated at 70 ◦ C for 10 min. Once the samples were cooled, they were centrifuged at
2000 rpm for 5 min and the aqueous layer was removed. The remaining solution, containing lipids, was dried under a gentle stream of N2 and resuspended in 1 mL chloroform.
Twenty microliters of the total lipids solution was removed for subsequent analyses and
diluted to a concentration of 2 µg/µL. The remaining sample was dried again under a
gentle stream of N2 .
Separation and analysis of lipid classes was accomplished by thin layer
chromatography–flame ionization detection (TLC-FID) using the Iatroscan MK-6 TLC/FID
Analyzer System (Shell-USA, Federicksburg, VA, USA). The system is composed of 10 quartz
rods that are 15 cm in length and 0.9 mm in diameter, coated with a 75 µm layer of porous
silica gel particulates that are 5 µm in diameter (Shell-USA, Federicksburg, VA, USA) [60].
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Prior to application of samples, chromarods were repeatedly blank scanned in order to
burn off any impurities and activate the rods. Next, 1 µL of the 2 µg/µL lipid sample or
the reference standard was spotted onto the rods. Rods were developed in a TLC chamber
with benzene:chloroform:formic acid (70:30:0.5 v/v/v) to separate the neutral lipids until
the solvent front reached the 100 mark on the rod holder. Rods were subsequently removed
and dried at 60 ◦ C in a rod dryer (TK8, Iatron Inc, Tokyo, Japan) for 5 min. Rods were
analyzed using the following settings: 2 L/min atmospheric air, 160 mL/min hydrogen,
scanning speed of 3 s/cm. Areas under the curve for the peaks of interest were integrated
using PeakSimple 3.29 Software (SRI Instruments, Torrance, CA, USA) and expressed as a
percentage of the total area under the curve for all peaks analyzed.
In preparation for gas chromatography, the total lipids were fractioned using Supelco
Supelclear LC-NH2 sPE columns (Supelco, Bellefonte, PA, USA). Total lipid samples were
resuspended in chloroform to a concentration of 10 mg/mL. Once the columns were
conditioned, 300 µL of suspended sample was added and allowed to flow through the
column, then centrifuged at 1000 rpm for 1 min. Neutral lipids were eluted with 1.8 mL
of 2:1 chloroform:isopropanol (v/v), followed by centrifugation at 1000 rpm for 1 min.
Non-esterified fatty acids were eluted with 1.6 mL 98:2 isopropyl ether:acetic acid (v/v),
followed by centrifugation at 1000 rpm. Phospholipids were eluted with 3 mL of methanol,
followed by centrifugation at 1000 rpm for 1 min. Each sample was subsequently dried
under a gentle flow of N2 . Three hundred µg of each sample was then methylated by
adding 200 µL of Meth-HCl to the dried sample and incubated at 90 ◦ C for 45 min. Next,
800 µL of water and 500 µL of hexane were then added to each sample, with the hexane
layer extracted and put in a fresh tube. Following hexane extraction, samples were dried
under a gentle flow of N2 and resuspended in dichloromethane for injection into a 6890N
gas chromatograph (Hewlett Packard, Palo Alto, CA, USA) with a J&W Scientific HighResolution Gas Chromatography Column (DB-23, Agilent Technologies) and a flame
ionization detector. Fatty acids were identified by comparison of the relative retention time
with known standards (Supelco 37 component FAME mix, and Supelco PUFA No.3, from
Menhaden Oil).
2.11. Extraction and LC-MS/MS Method for the Analysis of Acylcarnitines and Amino Acids
Acylcarnitine and amino acid analysis was performed by the Analytical Facility for
Bioactive Molecules, The Hospital for Sick Children, Toronto, Canada. Ground tissue was
weighed out and a solution of 1:1 water:methanol was added to yield 25 mg/mL. Samples
were then homogenized and kept on ice. An equivalent of 5 mg of homogenized tissue was
added to an Eppendorf tube with an acylcarnitine internal standard (IS) mixture (NSK-B,
Cambridge Isotopes, Tewksbury, MA, USA) and an amino acid IS mixture (Arginine13 C , ADMA-d , citrilline-d , glutamic acid-d , ornithine-d , and leucine-d , Cambridge
6
7
7
2
7
10
Isotopes, and CDN Isotopes). Samples and standard mixtures were then acidified with
60 µL of 0.1% formic acid and then protein was precipitated using 1 mL of 0.3% formic
acid in acetonitrile. Tubes were then vortexed and centrifuged at 10,000 g for 10 min at
4 ◦ C. Supernatants were transferred to conical glass tubes and the remaining pellet in the
Eppendorf was re-suspended in an additional 1 mL 0.3% formic acid in acetonitrile and
vortexed and centrifuged again. The combined supernatants were dried under a gentle
flow nitrogen gas. Samples and standards were derivatized with 100 µL butanolic-HCL
3 N for 20 min at 65 ◦ C. Solvent was then removed under a gentle flow of nitrogen gas and
samples were reconstituted in 200 µL MPB (see below) and transferred to auto sampler
vials. Ten µL of the reconstituted sample was diluted 50× in the same solution for amino
acid analysis.
Extracted samples were injected onto a Kinetex HILIC 50 × 4.6 mm 2.6 µm column
(Phenomenex) connected to an Agilent 1290 HPLC system attached to a Q-Trap 5500 mass
spectrometer (AB Sciex, Framingham, MA, USA). Injected samples were eluted with a
gradient of mobile phases MPA: 90/10 5 mM ammonium formate pH 3.2/acetonitrile and
MPB: 10/90 5 mM ammonium formate pH 3.2/acetonitrile. For acylcarnitines, the gradient
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started at 4% MPA for 1 min, increasing to 45% for 0.65 min, holding for 0.05 min, and then
returning to 4% MPA for the remaining 3 min. For amino acids, the 50 × diluted samples
were eluted with a gradient of MPA, starting at 4% for 2.5 min and increasing to 75% MPA
until 6 min, holding at 75% MPA for 1 min, and then returning to 4% over the final 2.5 min.
Mass transitions were monitored for each sample and compared against known standard
mass transitions for species analyzed [61]. Data were collected and analyzed using Analyst
v1.6 (AB Sciex, Framingham, MA, USA). Qualitative area ratios were determined for each
species examined [61].
2.12. Statistical Analyses
A Shapiro–Wilks test was used to determine if data were normally distributed, then
data were Box−Cox transformed if necessary, prior to ANOVA. Two-way ANOVA was
employed to assess the main effect and the interaction effect of birth weight and postnatal
diet (GraphPad Software, San Diego, CA). A Bonferroni post hoc test was used to compare
NBW/CD versus LBW/CD, as well as NBW/WD versus LBW/WD. When comparing only
NBW and LBW at birth and during lactation period, two-tailed unpaired Student’s t-test
was used.
A principal component analysis (PCA) of the acylcarnitine and amino acid measurements was performed (SPSS Statistics, version 21.0; IBM SPSS, Armonk, NY, USA) to
reduce the dimensionality of the dataset while retaining as much of the variance as possible.
The metabolic principal components (PCs), defined as linear, orthogonal (uncorrelated)
combinations of the original metabolites, were ordered according to their decreasing ability
to explain variance in the original dataset. Only PCs with eigenvalues greater than 1 were
retained. The cumulative variance explained by the 9 PCs included in the resultant analysis
was 87.6%. The dataset was then rotated using an orthogonal varimax procedure. To
facilitate biological interpretation of the PCs, the associated weight loading factors for
each metabolite were examined and metabolites with a loading score greater than 0.5 are
reported for each factor. Tests of main effects of birth weight, diet, and birth weight by diet
interactions were performed using two-way ANOVA.
Data presented are min. to max. box and whisker plots or mean ± standard error
(SEM). Values of p < 0.05 were considered statistically significant for all analyses.
3. Results
3.1. Characteristics at Birth and Growth Performance during the Lactation Period
At the time of birth, LBW offspring displayed indications of growth restriction. Birth
weight/birth length, a measure of leanness, was significantly (p < 0.001) reduced in LBW
offspring, compared to NBW offspring (Table 1).
Table 1. Birth characteristics and lactation period growth.

NBW
LBW

Bi-Parietal
Distance
(cm)

CrownRump
Length (cm)

Abdominal
Circumference
(cm)

Ponderal
Index
(g/cm3 )

Birth
Weight/Birth
Length (g/cm)

Absolute
Growth Rate
(g/day)

%Increase
in Body
Weight

Fractional
Growth
Rate

2.16 ± 0.035
2.04 ± 0.039
*

15.49 ± 0.32
13.97 ± 0.38
**

11.56 ± 0.17
10.98 ± 0.24
p = 0.0544

0.029 ± 0.002
0.029 ± 0.002
ns

6.7 ± 0.21
5.46 ± 0.22
***

9.50 ± 0.26
8.29 ± 0.24
**

115.7 ± 3.79
149.6 ± 6.14
****

0.092 ± 0.002
0.113 ± 0.004
****

Data presented are mean ± standard error (SEM) for n = 20 NBW and n = 18 LBW offspring. Statistical significance was determined by
two-tailed unpaired Student’s t-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Biparietal distance (BPD), crown–rump length (CRL), and abdominal circumference
(AC) were reduced (p ≤ 0.05) in LBW versus NBW offspring (Table 1). During the lactation
period, LBW offspring exhibited an altered growth trajectory. LBW offspring showed
a 149.6% increase in their body weight over the course of the lactation period, a 29%
(p < 0.0001) greater increase than the NBW offspring (Table 1). The fractional growth rate
was also 23% greater (p < 0.0001) in LBW offspring compared to NBW (Table 1). However,
absolute growth rate (AGR) was reduced by 13% (p < 0.01) in LBW offspring (Table 1).
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3.2. Post-Weaning Growth Performance, Energy Intake, and Body Composition
During the post-weaning period, a difference (p < 0.01) in total mean AGR was
also observed in experimental groups, independent of time. Additionally, there were a
significant (p < 0.01) interactions between time and our experimental groups (Figure 2A).
NBW/CD offspring had an AGR of 7.38 ± 0.323 g from weaning until PND50, an AGR of
4.62 ± 0.23 g from PND51-110, and an AGR of 2.87 ± 0.47 g from PND111-145 (Figure 2A),
ultimately reaching a body weight of 825.2 ± 28.3 g at the time of tissue collection (PND145).
During the period from weaning until PND50, NBW/WD offspring displayed a 27%
reduction (p < 0.01) in AGR compared to NBW/CD offspring, whereas LBW/WD offspring
displayed a 34% reduction in AGR compared to NBW/CD offspring (p < 0.001; Figure 2A).
During the same period, no changes in mean AGR were observed in LBW/CD versus
NBW/CD. No significant differences in mean AGR were observed in the three groups
compared to NBW/CD for the period from PND51-110. From PND111 to the time of
euthanasia, LBW/CD offspring displayed a 52% reduction (p < 0.05) in AGR compared
to NBW/CD offspring (Figure 2A). Overall, WD-fed offspring remained significantly
(p < 0.05) lighter than CD-fed offspring at the time of tissue collection, with body weights
of NBW/WD: 732.3 ± 26.8 g; LBW/WD: 708.8 ± 19.8 g vs. NBW/CD: 825.2 ± 28.3 g;
LBW/CD: 747.9 ± 38.1 g. Compared to the NBW/CD group, LBW/WD animals had
significantly (p < 0.05) lower body weights at euthanasia.
Food intake (g consumed/day/kg body weight) was reduced as a main effect of
time but no significant differences in average food intake were observed between the
four experimental groups throughout the experiment (Figure 2B). However, calorie consumption (calories/day) was overall significantly (p < 0.0001) higher in WD-fed offspring,
independent of time (Figure 2C). From weaning–PND50, calorie consumption was 23%
higher in NBW/WD (p < 0.05) and 36% higher in LBW/WD (p < 0.001) offspring compared
to NBW/CD (Figure 2C).
From PND111–PND145, calorie consumption was higher 34% in NBW/WD (p < 0.05)
and 55% higher in LBW/WD (p < 0.001) when compared to NBW/CD (Figure 2C).
Overall, food efficiency (grams body weight gained/day/calories consumed/day)
was significantly (p < 0.0001) decreased in WD-fed offspring (Figure 2D). From weaning–
PND50, food efficiency was reduced by 39% in NBW/WD (p < 0.001) and by 52% in
LBW/WD (p < 0.001) offspring compared to NBW/CD. From PND51–110, NBW/WD
offspring showed a 35% reduction in (p < 0.01) food efficiency compared to NBW/CD,
whereas LBW/CD offspring showed a 50% reduction in (p < 0.01) food efficiency from
PND111–PND145 when compared to NBW/CD (Figure 2D).
Whole-body adipose tissue, as measured by CT at PND110, was significantly (p < 0.01)
reduced in WD-fed offspring, independent of birth weight (Figure 2E).
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3.3. Muscle Arteriole Density, Interstitial Fibrosis, and Fatty Infiltration
To determine arteriole densities, sections were stained for α-SMA at PND145 (Figure 3A).
Vessels positive for α-SMA were manually counted and normalized to total myofiber areas.
LBW guinea pigs, irrespective of the consumed postnatal diet, displayed a 22% decrease
in number of arterioles per myofiber area (p < 0.05, Figure 3B). There were no significant
differences in arteriole densities between dietary groups.
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Collagen deposition between myofiber bundles was determined using Masson’s
trichrome stain at PND145 (Figure 4A). All collagen areas were quantified, normalized
to total myofiber area, and reported as percentages. A tendency for increased interstitial
collagen deposition per myofiber area in LBW offspring, irrespective of diet, was observed
(p = 0.064, Figure 4B). Consumption of a postnatal Western diet at this age did not have
any significant effects on muscle fibrosis.
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The accumulation of adipocytes within muscle is a common manifestation of muscle pathology and was investigated in hematoxylin and eosin (H&E)-stained sections of
gastrocnemius from NBW and LBW offspring fed the CD or WD. Interstitial adipocytes
were not observed in histological images for any treatment groups (Figure 5); therefore, fat
deposition was not quantified.
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Glucose uptake at the level of the skeletal muscle was assessed using 18 F-FDG PET
and measuring the standard uptake value of radioactivity observed during the scans. No
significant differences in skeletal muscle glucose uptake were observed due to birth weight
or postnatal diet at either PND50 (Figure 6E) or PND110 (Figure 6F).
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As inhibition of NADH-linked β-hydroxy fatty acyl-CoA oxidation is known to promote accumulation of hydroxy acylcarnitines, we also sought to quantify these intermediates. We observed significant (p < 0.05) accumulation of the 3-β-hydroxylated forms of
C12, C14, C16, C18 and C18:1 in response to WD-feeding (p < 0.01, Figure 8C). Birth weight
was also associated with a significant accumulation of C16-OH acylcarnitine, with
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LBW/CD exhibiting more C16-OH than NBW/CD (p < 0.05, Figure 8C).
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As inhibition of NADH-linked β-hydroxy fatty acyl-CoA oxidation is known to
promote accumulation of hydroxy acylcarnitines, we also sought to quantify these intermediates. We observed significant (p < 0.05) accumulation of the 3-β-hydroxylated forms
of C12, C14, C16, C18 and C18:1 in response to WD-feeding (p < 0.01, Figure 8C). Birth
weight was also associated with a significant accumulation of C16-OH acylcarnitine, with
LBW/CD exhibiting more C16-OH than NBW/CD (p < 0.05, Figure 8C).
Clusters of amino acids, including the branched-chain amino acids (Leu, Iso, Val), as
well as Tyr and Phe, have recently been identified as strong predictors of increased risk
of developing diabetes and impaired insulin action, prompting us to investigate amino
acid profiles in the muscle of NBW and LBW offspring fed a postnatal CD or WD. In our
model, a main effect of birth weight on Glu concentration was observed, with LBW/CD
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acid profiles in the muscle of NBW and LBW offspring fed a postnatal CD or WD. In
model, a main effect of birth weight on Glu concentration was observed, with LBW/CD
displaying less Glu than NBW/CD group (p < 0.05, Figure 9A). Although not significant,
levels of Leu in LBW offspring, irrespective of postnatal diet, tended to increase (p = 0.053,
displaying less Glu than NBW/CD group (p < 0.05, Figure 9A). Although not significant,
Figure 9C). Additionally, we observed increased Ala, Asp, and Phe and reduced Cit as
levels of Leu in LBW offspring, irrespective of postnatal diet, tended to increase (p = 0.053,
main effects of WD, irrespective of birth weight (p < 0.05, Figure 9A,B).
Figure 9C). Additionally, we observed increased Ala, Asp, and Phe and reduced Cit as
main effects of WD, irrespective of birth weight (p < 0.05, Figure 9A,B).
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significant (p < 0.0001) main effect of diet was observed for the components of this factor,
highlighting postnatal diet as a major contributor to the acylcarnitine species associated
with this component.
PC2 was composed predominantly of the hydroxylated acylcarnitines derived from
C4, C12–C18, and C18:1, with contributions from C4 and C6. A potential contribution
(p = 0.076) of postnatal diet was observed for this PC.
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PC3 was made up of poly-unsaturated long-chain acylcarnitines, including C18:2,
C18:3, C20:4, and C22:5 acylcarnitine species, with a significant (p < 0.05) contribution of
postnatal diet to this cluster. PC4 (gluconeogenic amino acids) was composed of amino
acids, including Leu, Iso, Val, Tyr, and Phe. Birth weight was a potential (p = 0.075)
contributor to this PC.
Table 2. Exploratory PCA on acylcarnitine levels.
p Values for Main Effect
Factor

Metabolite
Description

Birth Weight

Diet

Birth Weight
and Diet

PC1, medium- &
long-chain acylcarnitines,
eigenvalue 12.6
(43.40%)

C2 (−0.715)
C8 (0.556)
C10 (0.797)
C12 (0.886)
C14 (0.801)
C16 (0.929)
C18 (0.836)
C14:1 (0.766)
C16:1 (0.877)
C18:1 (0.921)
C4 (0.865)
C6 (0.784)
C4· · · OH (0.721)
C12· · · OH (0.723)
C14· · · OH (0.783)
C16· · · OH (0.741)
C18· · · OH (0.814)
C18:1· · · OH (0.764)
C18:2 (0.807)
C18:3 (0.813)
C20:4 (0.716)
C22:5 (0.925)
Leu (0.723)
Ile (0.603)
Val (0.801)
Tyr (0.554)
Phe (0.673)

p = 0.273

p < 0.0001

p = 0.469

p = 0.415

p = 0.076

p = 0.569

p = 0.775

p = 0.022

p = 0.996

p = 0.075

p = 0.587

p = 0.459

PC2, hydroxylated
acylcarnitines, eigenvalue
3.9
(13.71%)

PC3, poly-unsaturated
long-chain acylcarnitines,
eigenvalue 3.3
(11.36%)
PC4, gluconeogenic amino
acids, eigenvalue 2.2
(7.53%)

Eigenvalues and percentage contributions to total sample variance are presented for the first four principal
components (PCs) of the model. Individual features of each component are displayed, along with rotated loading
coefficients when greater than 0.5. Values in parentheses next to each metabolite are the loading coefficients from
the PCA model, which is a measure of the importance of each metabolite to the factor. Parenthetical values next
to the eigenvalue represent the percentage of the total sample variation for each factor. Data are means ± SEM of
5 to 8 animals/experimental group (birth weight/diet group). Displayed P-values represent the main effect of
birth weight, diet, or their interaction using a regular two-way ANOVA.

3.8. Skeletal Muscle Insulin Signaling Signature
The phosphorylation of the β-subunit of the insulin receptor (IRβ) is required for
its activation and propagation of downstream signaling events. Phosphorylation of
IRβTyr1150/1151 was not altered by birth weight or diet (Figure 10). Protein kinase B (Akt) is
phosphorylated by phosphoinositide 3 (PI3)-kinase at two sites, Ser473 and Thr308 , which
are both required for full activation of this protein. At the Ser473 and Thr308 sites, phosphorylation was reduced in WD-fed offspring, irrespective of birth weight (p < 0.05 Figure 10).
Additionally, as a birth weight effect, phosphorylation at the Thr308 point was increased
(p < 0.05). Stress-induced kinases, including c-Jun N-terminal kinases (JNK), protein kinase
C (PKC)θ, and PKCε, are known to be activated in situations of oxidative stress or lipid
accumulation and insulin resistance. In our study, total protein level of PKCε was increased
as a main effect of birth weight, with LBW/CD displaying more PKCε level than NBW/CD
(p < 0.05, Figure 10). Total protein levels of PKCθ and PKCε were also significantly higher in
WD-fed animals (p < 0.05, Figure 10). JNK1-mediated disruption of insulin receptor/insulin
receptor substrate 1 (IRS1) interaction and the resulting insulin resistance are dependent
on IRS1 phosphorylation at both Ser302 and Ser307 . IRS1 is also phosphorylated at Ser307
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by IKKβ kinase. In the current study, while activation of JNK through phosphorylation at
Thr183 /Tyr185 was not altered by birth weight nor diet, phosphorylation of IRS1 at Ser302
increased in WD-fed offspring (p < 0.0001, Figure 10). Interestingly, IRS1 phosphorylation
at Ser302 was exacerbated in LBW/WD compared to NBW/WD (p < 0.001, Figure 10). The
activation of IKKβ through phosphorylation at Ser177/181 was also increased in WD-fed
offspring (p < 0.0001, Figure 10). The first step by which insulin increases energy storage or
utilization in muscle involves the regulated transport of glucose into cells, mediated by the
Nutrients 2021, 13, x FOR PEER REVIEW
21 of 31
facilitative glucose transporter 4 (GLUT4). While GLUT4 protein was not measured, total
GLUT5, was significantly (p < 0.0001) increased as a WD main effect (Figure 10).
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The rate-limiting step of mitochondrial β-oxidation, CPT1-catalyzed transport of
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acylcarnitines into the mitochondria, is often used as a marker of mitochondrial oxidative
capacity. We observed a significant (p < 0.05) decrease in CPT1b mRNA expression in LBW
offspring, irrespective of postnatal diet (Figure 11A). The 3-ketoacyl-CoA thiolase (KT),
the
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responsible
catalyzing
the removalβ-Oxidation
of acetyl-CoA from the fatty acid chain,
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mortality [62,63], but are also now recognized as setting the stage for an increased
4. Discussion
risk of metabolic dysregulations and metabolic syndrome (MetS) later in life [19,64–66].
Intrauterine growth restriction (IUGR) and low birth weight (LBW) are the results of
Central to MetS is muscle dysfunction, and in particular, muscle insulin sensitivity and
survival mechanisms adopted by the fetus following uteroplacental insufficiency (UPI),
metabolic function [67]. In addition, IUGR resulting in low birth weight (LBW) is now
a condition where the placenta is unable to deliver an adequate supply of nutrients and
oxygen to the fetus. These outcomes have immediate implications for neonatal morbidity
and mortality [62,63], but are also now recognized as setting the stage for an increased risk
of metabolic dysregulations and metabolic syndrome (MetS) later in life [19,64–66]. Central
to MetS is muscle dysfunction, and in particular, muscle insulin sensitivity and metabolic
function [67]. In addition, IUGR resulting in low birth weight (LBW) is now recognized
as a central programming factor in lifelong impairments in muscle development and
metabolism [24]. With IUGR/LBW outcomes continuing to increase [40] and the increasing
availability and consumption of energy-dense diets in society [68], a significant contributor
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to MetS [69], the present investigation sought to identify alterations in muscle metabolic
function. Specifically, the study focused on changes in skeletal muscle arteriole density,
fibrosis, amino acid and mitochondrial lipid metabolism, markers of insulin signaling, and
glucose uptake following UPI-induced IUGR/LBW independently, and in conjunction with
early postnatal exposure to a WD. The key findings from the present study are that UPIinduced IUGR/LBW and WD affect offspring skeletal muscle amino acid and acylcarnitine
profiles at early adulthood, and specific changes in muscle acylcarnitines in UPI-induced
IUGR/LBW offspring are exacerbated by the intake of a postnatal WD, in the absence
of obesity. Additionally, UPI-induced IUGR/LBW is associated with notable diminished
arteriole density and a significant increase in PKCε protein levels in skeletal muscle at
early adulthood, in the absence of alterations in skeletal muscle glucose uptake and wholebody glucose tolerance, all likely reflecting in utero programmed/unmasked impaired
muscle function.
The skeletal muscle extracellular matrix (ECM) provides a framework structure that
holds myofibers, blood capillaries, and nerves supplying the muscle [70], and alterations
in components of the ECM are associated with muscle dysfunction and impaired insulin
actions [17]. Impaired capillary density in muscle is apparent in diabetes in both lean and
obese rodents [71,72]. In addition, offspring of adverse suboptimal maternal nutrition have
demonstrated endothelial dysfunction and remodeling of skeletal muscle vasculature, with
limited microvascular and vasodilatory reserve [73]. Furthermore, there is evidence that
IUGR affects collagen content in skeletal muscle [74]. Interestingly, in the current study
in early adulthood, a significantly diminished number of arterioles per myofiber area in
LBW guinea pigs was observed, irrespective of the postnatal diet. Furthermore, skeletal
muscle of the LBW offspring also displayed increased interstitial collagen deposition
per myofiber area, although not significant, highlighting a potential role of UPI-induced
IUGR/LBW in modulating skeletal muscle fibrosis in early adulthood. These findings
suggest a deterioration of structural properties of UPI-induced IUGR/LBW skeletal muscle
into young adulthood, which could decrease vascular delivery compounds, such as insulin,
within the muscle skeletal muscle [11] with aging.
LBW in humans is associated with glucose intolerance and insulin resistance in the
skeletal muscle and the whole-body in the young [75–77], and excessive energy intake
may be regarded as a promoter of insulin resistance in humans [78]. In the current study
alterations in whole-body glucose tolerance or skeletal muscle glucose uptake were not
observed, however, UPI-induced IUGR/LBW was associated with an increase in total
PKCε protein in the gastrocnemius muscle. Overexpression of PKCε in skeletal muscle
precedes the onset of hyperinsulinemia and hyperglycemia and data suggest this overexpression may be causally related to the development of insulin resistance, possibly by
increasing the degradation of insulin receptors [79]. The mechanisms underlying the persistent postnatal change in PKCε at 4 months of age in UPI-induced IUGR/LBW are not
yet clear. Nevertheless, such alterations in PKCε protein in conjunction with the significant
diminished number of arterioles per myofiber area in the muscle of LBW offspring could
signal the beginning of insulin resistance pathogenesis. Indeed, skeletal muscle endothelial/microvascular dysfunction is linked to the insulin-resistant state [73,80], whereby an
altered capillary network and reduced diffusing capacity and hemodynamic regulation of
vessels in skeletal muscle is observed [81].
Protein kinase B/AKT plays a prominent role in mediating many of the metabolic
effects of insulin [82]. The protein kinases PKCs, PKC-θ, and PKCε provide a negative
regulation for AKT phosphorylation at Ser473 and Thr308 [83–85], which impairs AKT
activity. IRS-1 phosphorylation of Ser302 and Ser307 is increased in insulin-resistant mice;
furthermore, JNK1-mediated disruption of insulin receptor/IRS-1 interaction is dependent
on IRS-1 phosphorylation at Ser302 and Ser307 [86]. IRS-1 is also phosphorylated at Ser307
via several mechanisms, including insulin-stimulated kinases or stress-activated kinases
like IKKβ, which inhibit insulin signal transduction and contribute to peripheral insulin
resistance [87,88]. In the current study, a reduction in the phosphorylation of AKT at
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Ser473 and Thr308 and an increase in total protein levels of PKCθ, PKCε, phosphorylation
of IRS-1 at Ser302 , and IKKβ at Ser176/180 were associated with WD intake. An increased
IRS1 Ser302 phosphorylation in LBW/WD compared to NBW/WD offspring was also
observed, highlighting potentially an exacerbated insulin signaling defect in UPI-induced
IUGR/LBW offspring consuming the WD. Consistent with our observations, defects in
skeletal muscle insulin signaling including reduced phosphorylation in AKT at Ser473 ,
Thr308 , IRS-1 Ser302/307 phosphorylation, IKKβ Ser177/181 phosphorylation, and increased
total protein level of PKCθ have also been reported in the skeletal muscle of rats fed a
high-fat diet [89,90]. Interestingly and of note, in human and animal studies, young LBW
offspring have also been shown to display altered PKC and AKT signaling pathways
and these changes occurred in conjunction with maintenance of whole-body glucose tolerance [91,92], similar to what we have observed in our LBW and WD cohorts. It has
been postulated that changes in expression and phosphorylation of the insulin signaling
intermediates precedes the development of overt IR and glucose intolerance [92], providing
a molecular signature associated with early stages, or pre-clinical status, of disease progression [93]. Therefore, the predominantly diet-associated changes in PKCs levels, AKT,
IKKβ, and IRS1 phosphorylation status, in conjunction with the maintained glucose muscle
glucose uptake and the increased PKCε and GLUT5 protein in LBW offspring, highlight
that at this young age, both WD and UPI-induced IUGR/LBW offspring present an early
stage of insulin resistance pathogenesis resembling a pre-diabetic state, as described in
other reports [94].
Increasing dietary saturated fatty acid (SFA) consumption induces insulin resistance
with concomitant increases in muscle diacylglycerol (DAG), while diets rich in n-6 polyunsaturated fatty acids appear to prevent insulin resistance by directing fat into triglycerides
(TG), rather than other lipid metabolites [95]. In the current study, increased levels of SFAs,
including myristic fatty acid, were observed in the skeletal muscle of WD-fed offspring,
along with reductions in the omega-6 and omega-3 poly-unsaturated fatty acids in the
neutral lipid fraction, which have also been implicated in reduced insulin sensitivity [95,96].
The alterations in fatty acids levels observed in the skeletal muscle of WD-fed offspring
appear to mirror the composition of the dietary fats consumed in the WD [45], and may
contribute to the alterations in AKT, IRS1, and IKKβ phosphorylation and PKC levels noted
in these offspring. Indeed, increased availability of fatty acids has been linked to skeletal
muscle changes in key insulin signaling components and insulin resistance [97,98].
The muscle fatty acid profile was, however, unaltered in the LBW CD offspring muscle,
prompting further investigation into mitochondrial and amino acid metabolism readouts
as an alternative theory to explain the observed increased PKCε in the muscle of LBW
offspring because overexpression of PKCε is causally related to the development of insulin
resistance, possibly by increasing the degradation of insulin receptors [79]. Interestingly,
several medium- and long-chain acylcarnitines were significantly increased in LBW CD or
WD offspring independently. Acylcarnitine derangements similar to our results have been
previously described in human IUGR cord blood samples at birth [28], in the skeletal muscle
mice fed a high-fat diet [6], and in the serum of pre-diabetic and diabetic patients [32].
Our results also showed an interactive effect of LBW and postnatal WD consumption on
accumulation of medium- and long-chain acylcarnitines, findings that are similar to data
that were previously reported regarding the plasma of protein-restriction-induced LBW
rats fed a high-fat/high-sucrose–maltodextrin diet during adulthood for 10 weeks [99].
Altogether, these data shed light on unique muscle metabolic derangements in the young
adult LBW CD- and WD-fed offspring.
Acylcarnitines arise from the conjugations of acyl-coenzyme A with carnitine for the
transport of long-chain fatty acids across the inner mitochondrial membrane for β-oxidation,
and skeletal muscle is thought to be a principal contributor to the serum acylcarnitine
pool [6]. Acylcarnitines are known to accumulate in situations of incomplete fatty acid
oxidation and mitochondrial overload, where they are indicative of impairment of substrate
flux through the TCA cycle and oxidative phosphorylation [6,100,101]. For example,
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chronic overnutrition leads to fatty acid oxidation rates that outpace the tricarboxylic
acid cycle (TCA). This imbalanced environment exacerbates incomplete β-oxidation and
leads to intramitochondrial accumulation of acyl-CoAs and respective acylcarnitines, a
situation termed mitochondrial overload [6,100]. Carnitine palmitoyltransferase CPT1b, is
the mitochondrial enzyme that catalyzes the first and most essential step in β-oxidation
of long-chain fatty acids [102], and in the current study, CPT1b mRNA was reduced in
LBW offspring, irrespective of postnatal diet, indicating a potential defect in β-oxidation
as indicated in the soleus of IUGR rats [103]. Additionally, 3-ketoacyl-CoA thiolase (KT)
mRNA, the enzyme responsible for catalyzing the removal of acetyl-CoA from the fatty
acid chain [102], was also reduced in LBW offspring. These are indicators of a defect in
the oxidative process that would slow down the rate of β-oxidation and impair substrate
utilization through the remaining steps of the oxidative process, preventing complete
oxidation of the fatty acid chains. However, the reduced levels in the expression of
these fatty acid catabolism and oxidative genes were LBW-specific, highlighting that the
accumulation of acylcarnitines in the WD-fed offspring are likely due to alternate defects
in other components along the oxidative pathway. Indeed, palmitate in phospholipids was
decreased in WD offspring and the top components of our principal component analysis
were composed primarily of medium- and long-chain acylcarnitines, which explained the
sample variance more than any other factor of the model, with a significant main effect of
WD observed in this cluster. As such, it is possible that the defects, inducing acylcarnitine
accumulation in LBW offspring versus WD-exposed offspring occur at different levels of
the fatty acid catabolism process, namely during β-oxidation or oxidative phosphorylation
in LBW offspring, and the TCA cycle in the WD-exposed offspring. These differential
mechanisms, when superimposed upon one another in the LBW/WD offspring, would
have the potential to impair the oxidative process to a greater extent, promoting increased
acylcarnitine accumulation, similar to the interactive effect observed in C8, C10, C12, C14:1,
C16, and C18 acylcarnitine levels. As such, postnatal consumption of a WD following a
UPI-induced IUGR/LBW may exacerbate mitochondrial overload, promoting increased
accumulation of acylcarnitine intermediates.
Accumulation of acylcarnitines and amino acids may be at play early in diabetic progression, along with changes in DAG content and ceramide lipid intermediates [18,32,104].
Indeed, studies have highlighted that long-chain acylcarnitines interfere with muscle insulin signaling at the level of AKT phosphorylation and are associated with muscle insulin
resistance [7]. Moreover, altered insulin sensitivity in the absence of DAG accumulation has
been observed in pre-diabetic men [105]. Consistent with these previous reports, we did not
observe any significant accumulation of triglycerides or DAG in the skeletal muscle of WD
offspring. Taken together, the increase accumulation of short- and long-chain acylcarnitines
in LBW and WD offspring suggest such changes as predictive of impaired muscle insulin
signaling markers, namely increased PKCs, increased IKKβ and IRS1 phosphorylation,
and reduced AKT phosphorylation in these offspring.
Amino acids are the basic units constituting proteins; they can maintain nitrogen
balance, can be transformed into sugar or fat, and are involved in the structures of enzymes,
hormones, and some vitamins [106]. In the present study, significant reductions in Glu and
a trend of increased Leu in skeletal muscle of LBW offspring, irrespective of WD, were
identified. In a UPI-induced IUGR sheep model, fetuses displayed reduced net uptake rates
of essential amino acids, including Glu and branch chain amino acids (BCAAs: Leu, Val
and Iso), Lys, Thr, Phe, His, and Trp in hindlimb muscle compared to control fetuses [26].
Additionally, research suggests that serum Glu levels in nascent MetS were significantly
decreased compared to controls [18] and Glu can be used as an alternative energy source in
patients with metabolic disorders [107]. Thus, decreased Glu in skeletal muscle of LBW
guinea pig offspring might suggest that this amino acid is being used as an alternative
energy source, leading to its depletion.
The amino acids, Ala, Asp, and Phe, were also significantly elevated in skeletal muscle
of WD-fed offspring, an interesting observation, given high serum levels of these amino
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acids, namely Ala and Phe, are found in pre-diabetes or MetS [107]. Ala is a glucogenic
amino acid that can facilitate glucose metabolism, help alleviate hypoglycemia, and improve the body’s energy [106], similar to Asp, which is also a glucogenic amino acid
and necessary for protein synthesis in mammalian cells [108]. Additionally, Phe is a
glucogenic/ketogenic amino acid used to produce proteins and important molecules, and
elevated Phe levels are associated with severe metabolic disturbance [109]. Previous observations of the impact of postnatal exposure to a high-fat diet have reported a reorganization
of amino acid metabolism involving tissue-specific effects, and in particular, a decrease in
the relative allocation of amino acid to oxidation in several peripheral tissues, including
tibialis anterior muscles of young adult rats [110]. As such, one could speculate that the
WD offspring in the current study had a reduction in the relative allocation of certain
amino acids to oxidation in skeletal muscle that may have contributed to their elevation,
highlighting potential amino acid oxidation defects, which should be further investigated.
Finally, associations of changes in plasma and muscle BCAA (Val, Leu/Iso) and other
amino acids (Phe, Tyr, Ala) with muscle insulin resistance, whole body insulin resistance,
and type 2 diabetes have been extensively reported and subsequently demonstrated with
broad-based metabolomic investigations [8,18]. Taken together, the increased accumulation
of certain amino acids in LBW and WD offspring may also be related to impaired muscle
PKC levels, as well as IKKβ, IRS1, and Akt phosphorylation in these offspring, given that
BCAAs, particularly Leu, inhibit early steps in insulin action critical for glucose transport,
including decreased insulin-stimulated tyrosine phosphorylation of IRS-1 and IRS-2 and a
marked inhibition of insulin-stimulated phosphatidylinositol 3–kinase [10].
5. Conclusions
IUGR, culminating in LBW and postnatal WD consumption, is, both independently
and in conjunction, associated with diminished arteriole density, mitochondrial lipid
metabolism, and markers of insulin signaling in young adult lean offspring. Certainly, fetal
hypoxia subsequent to UPI is associated with promoted oxygenated blood flow to the heart
and reduced umbilical blood supply to organs such as skeletal muscle, an adaption which
is understood to reprogram muscle mitochondrial lipid metabolism in utero, likely through
altered epigenetic regulation [111]. The current report further highlights that consumption of WD following UPI-induced IUGR/LBW likely unmasks LBW-induced evidence
of metabolic dysfunction, exacerbating skeletal muscle acylcarnitine accumulation and
promoting mitochondrial overload. These persistent postnatal alterations in acylcarnitine
accumulation, and the associated changes in the skeletal insulin signaling, occur early
in postnatal life, without body composition changes, weight gain, or overt disruption of
whole-body glucose tolerance, are suggestive of a pre-diabetic situation in these young
male offspring.
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